SANDO Syndrome: A Patient Guide

Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome, commonly known as SANDO, is a rare and complex genetic disorder that affects how the body produces energy. It belongs to a group of conditions caused by mutations in the POLG gene. The POLG gene is responsible for maintaining the DNA inside your mitochondria—the “power plants” of your cells ^[1][2]. When these power plants cannot function correctly, tissues that require high amounts of energy, particularly the nerves and muscles, begin to fail. Because SANDO is a genetic condition, it is a lifelong diagnosis that requires a specialized, proactive approach to medical care ^[2][3].

The name SANDO describes a characteristic “triad” of symptoms, though not every patient will experience all three components equally. The features include:

1. Sensory ataxic neuropathy: Damage to the sensory nerves that tell your brain where your limbs are in space, leading to significant balance issues and unsteadiness.
2. Dysarthria: Difficulty with speech clarity and coordination, which is frequently accompanied by challenges in swallowing (dysphagia).
3. Ophthalmoparesis: Weakness of the eye muscles, resulting in limited eye movement, double vision, or drooping eyelids (ptosis) ^[1][4][3].

The way these symptoms manifest, and the age at which they first appear, differ greatly from person to person ^[3][5].

Critical Medication Warning

One of the most important pieces of information for anyone diagnosed with SANDO or any POLG-related disorder is the severe danger of a specific medication called valproic acid (also known as valproate, sodium valproate, divalproex, or Depakote).

In individuals with POLG mutations, this medication carries a high risk of causing sudden, catastrophic, and potentially fatal liver failure ^[6][7]. This is a severe medication contraindication, not a typical immune allergy. It is vital that this avoidance alert is prominently marked in your medical records and communicated to every healthcare provider you visit, particularly emergency room staff, as valproate is often used to treat seizures or migraines in the general population ^[7].

Managing SANDO

Although SANDO is a progressive condition without a known cure, it is manageable through the dedicated support of a multidisciplinary care team. This team typically includes neurologists, speech-language pathologists, physical therapists, and eye specialists who work together to address symptoms safely ^[8][4].

By focusing on personalized monitoring—such as instrumental swallowing assessments to prevent lung infections, physical therapy to manage fall risks, and individualized sick-day plans—you and your doctors can focus on maintaining your independence and quality of life. While the path with SANDO involves chronic monitoring and adaptation, having an informed plan ensures you are not navigating this rare diagnosis alone ^[8][9].